Syra Health and Nora Mental Health Announce Telehealth Partnership to Expand Access to Mental and Behavioral Health Services Across Indiana

Collaboration connects AI-powered digital behavioral health platform, Syrenity, with licensed therapists to deliver seamless, affordable care

CARMEL, Ind., April 2, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today a partnership with Nora Mental Health to expand access to mental and behavioral health services across Indiana through telehealth integration with Syra Health's Syrenity behavioral health solution.

This partnership connects Nora Mental Health's licensed therapists with individuals using the Syrenity app, creating a seamless pathway from digital mental health support to clinical care. The collaboration is designed to improve access to affordable, sustainable mental health services, particularly in rural and underserved communities where provider shortages and stigma remain significant barriers to care.

Under the partnership, individuals identified through Syrenity's new AI-driven risk stratification feature as having low- to moderate-acuity mental health needs may be referred to Nora Mental Health for clinical services delivered via telehealth or in person, as clinically appropriate.

The Syrenity solution is dually focused on prevention and intervention and operates on Syra Health's proprietary Guardrails framework, reflecting the company's commitment to responsible AI in healthcare. Syra Guardrails keeps AI in bounds through pre-generative content and transparent private server infrastructure. Syrenity includes cognitive behavioral therapy, an AI-powered journal for reflection and engagement, and real-time reporting that reduces costly hours spent by the patient bringing the therapist up to speed.  

Syrenity was evaluated as part of a clinical research study conducted by Indiana University, which demonstrated measurable improvement in depression symptoms and other key outcomes for individuals with access to the app compared to those without access.

As part of the collaboration, Nora Mental Health will also participate in ongoing evaluation of the Syrenity platform, providing clinical feedback to help enhance platform functionality, user experience, and clinical integration. Both organizations will maintain full compliance with HIPAA and all applicable federal and state privacy laws.

Nora Mental Health operates in 16 states across the United States and specializes in anxiety, depression, trauma, life transitions, and other mental health needs. The initial partnership will focus on Indiana, with the potential for regional or national expansion in the future.

Syrenity is available as a business-to-business solution for health plans, health systems, and large employers. It is also available as a direct-to-consumer product for download on the Apple App Store and Google Play.

About Syra Health

Syra Health is an integrated healthcare solutions company serving government and commercial healthcare organizations with innovative solutions that improve health outcomes. We specialize in healthcare prevention, expanding access, and delivering affordable solutions. Our healthcare analytics capabilities provide proactive, actionable insights and data-driven intelligence, and our HIPAA-compliant and fully accessible digital health solutions enable measurable health outcomes in highly regulated healthcare environments. Through training and education, we help healthcare organizations reduce costs and deliver consistent, high-quality care.

About Nora Mental Health
Nora Mental Health is a mental health provider organization offering therapy services for anxiety, depression, trauma, life transitions, and more, with a focus on accessible, high-quality mental health care delivered by licensed clinicians across multiple states.

Forward-Looking Statements

Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2025, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact
Christine Drury
IR/PR
Syra Health
463-345-5180
[email protected]

SOURCE Syra Health